the only thing that is important is PNV continue its sales growth not how many academic journal articles are published. It is no doubt pleasing that some many academic are choosing to publish on BTM, but at the end of the day, we need to make increasing sales and turn a profit. The more the merrier for everybody from shareholders to doctors to patients.
The Clinicians Speak, page-587
-
- There are more pages in this discussion • 447 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.36 |
Change
0.050(2.16%) |
Mkt cap ! $1.628B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.39 | $2.33 | $2.230M | 946.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3861 | $2.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.38 | 20817 | 3 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |